These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 17606561)

  • 1. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
    Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
    Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
    Carraro E; Trevisi E; Martinuzzi A
    Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
    El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
    J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.
    Kawano A; Yanagizono T; Kadouchi I; Umezaki T; Chosa E
    J Orthop Sci; 2018 Mar; 23(2):389-393. PubMed ID: 29146092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AbobotulinumtoxinA Efficacy and Safety in Children With Equinus Foot Previously Treated With Botulinum Toxin.
    Dabrowski E; Bonikowski M; Gormley M; Volteau M; Picaut P; Delgado MR
    Pediatr Neurol; 2018 May; 82():44-49. PubMed ID: 29625849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
    Bar-On L; Van Campenhout A; Desloovere K; Aertbeliën E; Huenaerts C; Vandendoorent B; Nieuwenhuys A; Molenaers G
    Arch Phys Med Rehabil; 2014 Mar; 95(3):515-23. PubMed ID: 23994052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC; Lin IL; Chou TF; Lee HM
    J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
    Büyükavcı R; Büyükavcı MA
    Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
    J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
    Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
    Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
    Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
    Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy].
    Kurenkov AL; Klochkova OA; Bursagova BI; Karimova HM; Kuzenkova LM; Mamedyarov AM; Namazova-Baranova LS; Agranovich OV; Agranovich AO; Soboleva OA; Khapaeva MM; Batysheva TT; Sarzhina MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):37-44. PubMed ID: 29265085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
    Ade-Hall RA; Moore AP
    Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.
    Ubhi T; Bhakta BB; Ives HL; Allgar V; Roussounis SH
    Arch Dis Child; 2000 Dec; 83(6):481-7. PubMed ID: 11087280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
    Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
    J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
    Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
    Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study.
    Unlu E; Cevikol A; Bal B; Gonen E; Celik O; Kose G
    Clinics (Sao Paulo); 2010 Jun; 65(6):613-9. PubMed ID: 20613938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.